Literature DB >> 18682400

Mutations targeting intermodular interfaces or calcium binding destabilize the thrombospondin-2 signature domain.

C Britt Carlson1, Kristin A Gunderson, Deane F Mosher.   

Abstract

Thrombospondins (THBSs) are a family of secreted calcium-binding glycoproteins with roles in angiogenesis, cell motility, apoptosis, cytoskeletal organization, and extracellular matrix organization. The THBS-2 signature domain (three epidermal growth factor (EGF)-like modules, a wire module with 13 calcium-binding repeats, and a lectin-like module) binds 30 calcium ions and forms extensive interactions among its parts. We explored the significance of these structural elements by examining the impact of 10 different mutations known to result in pseudoachondrodysplasia or multiple epiphyseal dysplasia when found in the homologous wire and lectin-like modules of thrombospondin-5 (THBS-5). A variety of observations indicate that the mutations result in unstable THBS-5 proteins that aggregate in the endoplasmic reticulum. We introduced the mutations into homologous sites of a THBS-2 construct, for which the crystal structure is known, and determined the effects of the mutations on structure as assayed by differential scanning calorimetry and expression of the epitope for the 4B6.13 conformation-sensitive antibody. Abnormalities were found in one or more of several readouts: stability of interactions between the wire and lectin-like modules, stabilities of the EGF-like and wire modules, expression of the 4B6.13 epitope in soluble protein, and expression of the 4B6.13 epitope in substrate-adsorbed protein at different calcium concentrations. The patterns of abnormalities support the idea that the EGF-like, wire, and lectin-like modules constitute a dynamic and interactive calcium-sensitive structure in which a distortion at one site is transmitted to distal sites, leading to global changes in the protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682400      PMCID: PMC2555992          DOI: 10.1074/jbc.M803842200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Expression of recombinant matrix components using baculoviruses.

Authors:  Deane F Mosher; Kristin G Huwiler; Tina M Misenheimer; Douglas S Annis
Journal:  Methods Cell Biol       Date:  2002       Impact factor: 1.441

2.  Dobzhansky-Muller incompatibilities in protein evolution.

Authors:  Alexey S Kondrashov; Shamil Sunyaev; Fyodor A Kondrashov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

3.  Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain.

Authors:  Quinn Kleerekoper; Jacqueline T Hecht; John A Putkey
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

4.  Interactions among the three structural motifs of the C-terminal region of human thrombospondin-2.

Authors:  Tina M Misenheimer; Blue-leaf A Hannah; Douglas S Annis; Deane F Mosher
Journal:  Biochemistry       Date:  2003-05-06       Impact factor: 3.162

Review 5.  The thrombospondins.

Authors:  Josephine C Adams; Jack Lawler
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

6.  Apoptosis staining in cultured pseudoachondroplasia chondrocytes.

Authors:  J Duke; D Montufar-Solis; S Underwood; Z Lalani; J T Hecht
Journal:  Apoptosis       Date:  2003-03       Impact factor: 4.677

7.  Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats.

Authors:  Marc Kvansakul; Josephine C Adams; Erhard Hohenester
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

8.  Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.

Authors:  Yusuke Hashimoto; Takami Tomiyama; Yoshiki Yamano; Hiroshi Mori
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

9.  Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.

Authors:  J T Hecht; M Deere; E Putnam; W Cole; B Vertel; H Chen; J Lawler
Journal:  Matrix Biol       Date:  1998-08       Impact factor: 11.583

10.  Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.

Authors:  Robert Dinser; Frank Zaucke; Florian Kreppel; Kjell Hultenby; Stefan Kochanek; Mats Paulsson; Patrik Maurer
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

View more
  6 in total

Review 1.  Thrombospondin-4 in tissue remodeling.

Authors:  Olga Stenina-Adognravi; Edward F Plow
Journal:  Matrix Biol       Date:  2017-11-11       Impact factor: 11.583

Review 2.  The thrombospondins.

Authors:  Josephine C Adams; Jack Lawler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

Review 3.  Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork-A review.

Authors:  Kate E Keller; Donna M Peters
Journal:  Clin Exp Ophthalmol       Date:  2022-01-17       Impact factor: 4.383

4.  The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.

Authors:  Kemin Tan; Mark Duquette; Andrzej Joachimiak; Jack Lawler
Journal:  FASEB J       Date:  2009-03-10       Impact factor: 5.191

5.  Dissection of Thrombospondin-4 Domains Involved in Intracellular Adaptive Endoplasmic Reticulum Stress-Responsive Signaling.

Authors:  Matthew J Brody; Tobias G Schips; Davy Vanhoutte; Onur Kanisicak; Jason Karch; Bryan D Maliken; N Scott Blair; Michelle A Sargent; Vikram Prasad; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2015-10-12       Impact factor: 4.272

6.  Defective Flux of Thrombospondin-4 through the Secretory Pathway Impairs Cardiomyocyte Membrane Stability and Causes Cardiomyopathy.

Authors:  Matthew J Brody; Davy Vanhoutte; Tobias G Schips; Justin G Boyer; Chinmay V Bakshi; Michelle A Sargent; Allen J York; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2018-06-28       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.